◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › B › BSX

Boston Scientific Corp (BSX) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Equipment · DATA UPDATED 2026-09-06

Boston Scientific Corp (BSX) operates in the Health Care Equipment industry and is headquartered in Marlborough, United States with about 59,000 employees. Its market capitalization is roughly $63 billion. In the fiscal year ended 2025-12-31, BSX reported $20.1B in revenue and $2.9B in net income.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.

Interactive charts & full statements → Open the BSX valuation workbench →

BSX Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$21.0B	$20.1B	$16.7B	$14.2B	$12.7B	$11.9B	$9.9B	$10.7B	$9.8B	$9.0B	$8.4B	$7.5B	$7.4B	$7.1B	$7.2B	$7.6B	$7.8B	$8.2B	$8.1B	$8.4B	$7.8B
Gross Profit	$14.9B	$13.9B	$10.3B	$8.8B	$7.7B	$7.5B	$5.6B	$6.9B	$6.5B	$5.9B	$5.3B	$4.6B	$4.6B	$4.5B	$4.6B	$4.7B	$4.8B	$5.2B	$5.1B	$5.4B	$5.1B
Gross Margin %	71.2%	69.0%	61.3%	62.0%	60.8%	62.8%	56.2%	64.1%	65.9%	64.9%	63.7%	61.0%	62.2%	63.5%	62.9%	61.4%	61.3%	63.2%	63.2%	64.6%	65.0%
Operating Income (EBIT)	$4.5B	$4.0B	$2.6B	$2.2B	$1.8B	$1.9B	$601M	$1.7B	$1.7B	$1.5B	$1.2B	$790M	$845M	$871M	$994M	$1.1B	$1.1B	$1.3B	$1.3B	$1.2B	$1.2B
Operating Margin %	21.5%	19.8%	15.7%	15.3%	14.4%	16.2%	6.1%	16.0%	17.7%	16.9%	14.7%	10.6%	11.5%	12.2%	13.7%	14.7%	13.8%	15.9%	16.1%	14.1%	15.8%
Net Income	$3.7B	$2.9B	$1.9B	$1.6B	$698M	$1.0B	($82M)	$4.7B	$1.7B	$104M	$347M	($239M)	($119M)	($121M)	($4.1B)	$441M	($1.1B)	($1.0B)	($2.0B)	($495M)	($3.6B)
Net Margin %	17.5%	14.4%	11.1%	11.2%	5.5%	8.8%	-0.8%	43.8%	17.0%	1.1%	4.1%	-3.2%	-1.6%	-1.7%	-56.1%	5.8%	-13.6%	-12.5%	-25.3%	-5.9%	-45.7%
EBITDA	$5.5B	$5.1B	$3.9B	$3.5B	$2.7B	$2.5B	$1.5B	$2.2B	$2.6B	$2.0B	$1.2B	$360M	$433M	$721M	($3.2B)	$1.6B	$149M	($108M)	($699M)	$940M	($2.3B)
Earnings Per Share (EPS)	$2.46	$1.93	$1.25	$1.09	$0.48	$0.73	$-0.06	$3.33	$1.19	$0.07	$0.25	$-0.18	$-0.09	$-0.09	$-2.89	$0.29	$-0.70	$-0.68	$-1.36	$-0.33	$-2.81
Shares Outstanding (M)	1,485M	1,494M	1,486M	1,464M	1,440M	1,434M	1,417M	1,411M	1,401M	1,393M	1,377M	1,341M	1,348M	1,341M	1,407M	1,519M	1,518M	1,508M	1,498M	1,487M	1,274M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BSX Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$5.4B	$5.2B	$5.3B	$5.1B	$5.1B	$4.7B	$4.6B	$4.2B
Gross Profit	$3.8B	$3.6B	$3.9B	$3.5B	$3.4B	$3.0B	$2.7B	$2.6B
Gross Margin %	70.7%	69.4%	74.5%	69.9%	67.7%	63.3%	58.6%	62.9%
Operating Income (EBIT)	$1.2B	$1.1B	$1.2B	$1.1B	$819M	$896M	$589M	$674M
Operating Margin %	21.6%	20.6%	22.8%	20.7%	16.2%	19.2%	12.9%	16.0%
Net Income	$907M	$1.3B	$668M	$755M	$793M	$674M	$566M	$469M
Net Margin %	16.7%	25.7%	12.6%	14.9%	15.7%	14.4%	12.4%	11.1%
EBITDA	$1.4B	$1.6B	$1.2B	$1.4B	$1.4B	$1.2B	$1.1B	$1.1B
Earnings Per Share (EPS)	$0.61	$0.89	$0.45	$0.50	$0.53	$0.45	$0.38	$0.32
Shares Outstanding (M)	1,485M	1,495M	1,496M	1,496M	1,493M	1,493M	1,490M	1,487M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BSX Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$4.5B	$4.5B	$3.4B	$2.5B	$1.5B	$1.9B	$1.5B	$1.8B	$310M	$1.4B	$972M	$600M	$1.3B	$1.1B	$1.3B	$1.0B	$325M	$835M	$1.2B	$934M	$1.8B
Capital Expenditures (CapEx)	$904M	$876M	$790M	$800M	$612M	$554M	$376M	$461M	$316M	$319M	$376M	$247M	$259M	$245M	$226M	$304M	$278M	$362M	$362M	$363M	$341M
Free Cash Flow (FCF)	$3.6B	$3.7B	$2.6B	$1.7B	$914M	$1.3B	$1.1B	$1.4B	($6M)	$1.1B	$596M	$353M	$1.0B	$837M	$1.0B	$704M	$47M	$473M	$854M	$571M	$1.5B
FCF Margin %	17.3%	18.2%	15.8%	12.0%	7.2%	11.1%	11.4%	12.8%	-0.1%	12.2%	7.1%	4.7%	13.7%	11.7%	14.3%	9.2%	0.6%	5.8%	10.6%	6.8%	19.2%
Dividends Paid	—	—	$0M	$28M	$55M	$55M	$28M	$28M	$28M	$28M	$0M	$0M	$759M	$1.8B	$371M	$0M	$0M	$0M	—	$508M	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BSX Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$1.5B	$348M	$1.4B	$1.3B	$1.3B	$541M	$1.5B	$1.0B
Capital Expenditures (CapEx)	$195M	$177M	$351M	$181M	$190M	$187M	$293M	$304M
Free Cash Flow (FCF)	$1.3B	$171M	$1.0B	$1.2B	$1.1B	$354M	$1.2B	$698M
FCF Margin %	23.5%	3.3%	19.2%	22.9%	21.7%	7.6%	25.5%	16.6%
Dividends Paid	—	—	—	—	—	—	$0M	$23M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BSX Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$45.2B	$43.7B	$39.4B	$35.1B	$32.5B	$32.2B	$30.8B	$30.6B	$21.0B	$19.0B	$18.1B	$18.1B	$16.8B	$16.7B	$17.2B	$21.3B	$22.1B	$25.2B	$27.1B	$31.2B	$31.1B
Cash & Cash Equivalents	$539M	$2.0B	$414M	$865M	$928M	$1.9B	$1.7B	$217M	$146M	$188M	$196M	$319M	$587M	$217M	$207M	$267M	$213M	$864M	$1.6B	$1.5B	$1.7B
Total Liabilities	$20.0B	$19.2B	$17.4B	$15.6B	$14.9B	$15.6B	$15.5B	$16.7B	$12.3B	$12.0B	$11.4B	$11.8B	$10.0B	$10.2B	$10.3B	$9.9B	$10.8B	$12.9B	$13.9B	$16.1B	$15.8B
Total Debt (Short + Long-Term)	$12.5B	$11.5B	$10.6B	$9.1B	$8.9B	$9.1B	$9.1B	$10.0B	$7.0B	$5.6B	$5.5B	$5.7B	$4.3B	$4.2B	$4.3B	$4.3B	$5.4B	$5.9B	$6.7B	$8.2B	$8.9B
Total Shareholders' Equity	$24.9B	$24.2B	$21.8B	$19.3B	$17.6B	$16.6B	$15.3B	$13.9B	$8.7B	$7.0B	$6.7B	$6.3B	$6.8B	$6.5B	$6.9B	$11.4B	$11.3B	$12.3B	$13.1B	$15.1B	$15.3B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BSX viewer.

BSX Metric Deep Dives

Other Companies in Health Care Equipment

ABT · Abbott Laboratories — $178 billion
ISRG · Intuitive Surgical — $141 billion
MDT · Medtronic — $118 billion
SYK · Stryker Corporation — $106 billion
EW · Edwards Lifesciences — $51 billion
BDX · Becton Dickinson — $49 billion
IDXX · Idexx Laboratories — $40 billion
DXCM · Dexcom — $34 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← BSVO All “B” companies BSY →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.